🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPharmacology & MechanismsPeptide degradation pathways — DPP-4 and NEP 24.11 cleavage sites Page 3

Peptide degradation pathways — DPP-4 and NEP 24.11 cleavage sites

PeptideChemSF Sun, May 31, 2026 at 12:39 PM 18 replies 345 viewsPage 3 of 4
sophie_paris
Member
212
890
Nov 2024
Paris, FR
Jun 1, 2026 at 4:51 PM#11
carl_compliance said:
Semaglutide structural biology relevant to the pharmacology: semaglutide is a 31-amino acid peptide with 94% homology to native GLP-1(7-36).

That reframing is the part I needed. Sending this to two other people who asked me the same thing last week.

Last edited: Jun 1, 2026 at 9:51 PM
13 11SallyK_inj, CryptoCarl, MariaRD and 10 others
Reply Quote Save Share Report
Dr.PulmRoch
Member
456
2,345
Jun 2024
Rochester, MN
Jun 2, 2026 at 10:31 AM#12

Adding the clinical framing, because it changes how the question reads. Take it one variable at a time. Almost every unanswerable question in these threads is unanswerable because three things changed in the same fortnight, and no amount of subsequent argument can untangle them after the fact.

14 12traveltech_sara, AttorneyGrant, DebRD_ATL and 11 others
Reply Quote Save Share Report
MikeFit_NJ
Senior Member
1,567
6,543
Apr 2024
New Jersey
Jun 3, 2026 at 4:12 AM#13
sean_dublin said:
I want to add the drug interaction perspective on the pharmacology.

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. The counter-case has not been addressed. Somebody upthread described the situation that does not fit, and the thread moved on rather than engaging with it, which is the failure mode this board is supposed to avoid.

15 13DeniseRN_TPA, SandraNC_45, Dr.EndoIndy and 12 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
quinn_sf
Member
489
2,123
Jun 2024
San Francisco, CA
Jun 3, 2026 at 9:52 PM#14

One concrete data point for the thread. Say what you would expect to see if you were wrong, before you look. It is a small discipline and it changes what you notice.

16 14andrew_nyc, Dr.EndoEP, GraceAZ_72 and 13 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Jun 4, 2026 at 3:31 PM#15

Moderator note: a couple of off-topic posts removed. Carry on.

Last edited: Jun 4, 2026 at 7:31 PM
17 15PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 14 others
Reply Quote Save Share Report

Similar Threads

GLP-1R desensitization — β-arrestin-mediated internalization18 replies
Biased agonism at GLP-1R — Gs vs β-arrestin signaling balance13 replies
Semaglutide albumin binding and the C-18 fatty acid linker17 replies
GIP receptor pharmacology — why GIP agonism enhances GLP-113 replies
Glucagon receptor signaling — hepatic glycogenolysis and lipolysis16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register